Zymeworks Inc. Common Stock (ZYME) — Cash Flow-to-Debt Ratio
Zymeworks Inc. Common Stock (ZYME) has a Cash Flow-to-Debt Ratio of -0.41x as of September 2025, meaning its operating cash flow of $-31.41 Million could theoretically repay 0% of its total liabilities ($77.20 Million) in one year. See Zymeworks Inc. Common Stock free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zymeworks Inc. Common Stock Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Zymeworks Inc. Common Stock across 11 annual periods. Also explore ZYME net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zymeworks Inc. Common Stock (2014–2024)
Year-by-year debt coverage analysis for Zymeworks Inc. Common Stock. For market capitalisation and broader financial context, see ZYME market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.89x | $-110.04 Million | $124.32 Million | ▲ +13.2% |
| 2023 | -1.02x | $-118.30 Million | $116.07 Million | ▼ -210.2% |
| 2022 | 0.93x | $144.11 Million | $155.77 Million | ▲ +167.3% |
| 2021 | -1.37x | $-192.45 Million | $140.04 Million | ▼ -16.6% |
| 2020 | -1.18x | $-151.40 Million | $128.45 Million | ▼ -76.4% |
| 2019 | -0.67x | $-81.85 Million | $122.52 Million | ▼ -276.5% |
| 2018 | 0.38x | $24.18 Million | $63.87 Million | ▲ +2583.7% |
| 2017 | 0.01x | $219.00K | $15.53 Million | ▲ +103.4% |
| 2016 | -0.41x | $-35.25 Million | $84.99 Million | ▲ +90.8% |
| 2015 | -4.52x | $-22.17 Million | $4.91 Million | ▼ -601.8% |
| 2014 | -0.64x | $-7.02 Million | $10.90 Million | — |